Recently Placed & Recent News
Ionis Director, Global HEOR, Rare Disease Immunology, Successfully Placed by The Chase Group
Successful Placement at Avidity
The Chase Group Successfully Completes Search for Amyloidosis Medical Affairs Leader
The Chase Group Identifies Chief Medical Officer for Arcturus Therapeutics
The Chase Group Secures VP, Head of Regulatory Affairs, for Checkmate Pharmaceuticals
The Chase Group Secures Clinical Operations Leadership for Alexza Pharmaceuticals
The Chase Group Successfully Completes Search for Vice President, Research & Development at Alexza Pharmaceuticals
The Chase Group Successfully Places David Geller, MD as Head of Pulmonary & Rare Disease Clinical Development for Arcturus Therapeutics
The Chase Group Successfully Secures Vice President, Head of Medical Development for Checkmate Pharmaceuticals
Search Executed by The Chase Group, Inc. Results in Successful Appointment of Dr. Christophe Hotermans as SVP, Global Medical Affairs for Akcea Therapeutics
Appointment of William Andrews, M.D. as Chief Medical Officer at Akcea Therapeutics Successfully Completed by The Chase Group
The Chase Group Secures New Leader for Informatics & Computational Biology at the Allen Institute for Immunology
The Chase Group Successfully Completes the Appointment of Carla Poulson as Senior Vice President/Chief Human Resources Officer at Akcea Therapeutics
Partnership With The Chase Group Results in Successful Placement for Eisai Global Oncology Business Unit
Aeglea Biotherapeutics Secures Another Executive for their Clinical Development Leadership Team
Aeglea BioTherapeutics Builds Rare Disease Clinical Development Team Through Partnership With The Chase Group, Inc.
Ionis Pharmaceuticals Secures Associate Director, Investor Relations
A Successful Placement at Eisai, Inc.
The Chase Group Successfully Completes Vice President, Clinical Development, Respiratory for Ionis Pharmaceuticals
Vice President of Drug Safety for Ionis Pharmaceuticals Secured
Ionis Engages The Chase Group to Continue Building QA Team